These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27927696)

  • 1. Gene expression signature: a powerful approach for drug discovery in diabetes.
    Sithara S; Crowley TM; Walder K; Aston-Mourney K
    J Endocrinol; 2017 Feb; 232(2):R131-R139. PubMed ID: 27927696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Drugs to Target the Diabetes Epidemic.
    Turner N; Zeng XY; Osborne B; Rogers S; Ye JM
    Trends Pharmacol Sci; 2016 May; 37(5):379-389. PubMed ID: 26900045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery.
    Pantaleao SQ; Fujii DGV; Maltarollo VG; da C Silva D; Trossini GHG; Weber KC; Scott LPB; Honorio KM
    Med Chem; 2017; 13(8):706-720. PubMed ID: 28530546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Prediction of Potential Drug Combinations for Type 2 Diabetes Mellitus by an Integrated Network and Transcriptome Analysis.
    Teng D; Gong Y; Wu Z; Li W; Tang Y; Liu G
    ChemMedChem; 2022 Feb; 17(3):e202100620. PubMed ID: 34755485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.
    Janero DR
    Expert Opin Drug Discov; 2014 Mar; 9(3):221-8. PubMed ID: 24397872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Discovery and Development of Type 2 Diabetes Mellitus: Modern-Integrative Medicinal Approach.
    Ghosh D; Parida P
    Curr Drug Discov Technol; 2016; 13(2):60-7. PubMed ID: 27074851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoughts on the progression of type 2 diabetes drug discovery.
    Bhatt HB
    Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intensive efforts for future antidiabetic agents].
    Berne C
    Lakartidningen; 2010 Nov 10-16; 107(45):2815-9. PubMed ID: 21179868
    [No Abstract]   [Full Text] [Related]  

  • 10. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
    Chang S; Chen JY; Chuang YJ; Chen BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of type II diabetes mellitus in drug discovery.
    Baribault H
    Methods Mol Biol; 2010; 602():135-55. PubMed ID: 20012397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Models of Type 2 Diabetes Mellitus in Drug Discovery.
    Baribault H
    Methods Mol Biol; 2016; 1438():153-75. PubMed ID: 27150090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging topics in type 2 diabetes: new mechanisms leading to new treatments?
    Seedorf K; Ferré P
    Curr Opin Pharmacol; 2009 Dec; 9(6):733-6. PubMed ID: 19896899
    [No Abstract]   [Full Text] [Related]  

  • 14. Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes.
    Costa V; Federico A; Pollastro C; Ziviello C; Cataldi S; Formisano P; Ciccodicola A
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining of protein based biomarkers for type 2 diabetes mellitus.
    Khan AR; Awan FR
    Pak J Pharm Sci; 2012 Oct; 25(4):889-901. PubMed ID: 23010011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of synthetic drugs for type 2 diabetes drug discovery.
    Safavi M; Foroumadi A; Abdollahi M
    Expert Opin Drug Discov; 2013 Nov; 8(11):1339-63. PubMed ID: 24050217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
    Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
    Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus : A comprehensive summary for antidiabetic drugs.
    Li J; Lian H
    Arch Pharm Res; 2016 Jun; 39(6):731-46. PubMed ID: 27230777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaco-proteomic analysis: application of proteomic analysis to the discovery and development of new drugs].
    Chapal N; Laplanche M; Ribes G; Pau B; Garin J; Petit P
    J Soc Biol; 2002; 196(4):317-22. PubMed ID: 12645303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.